MA55951A - Nouveau gardnerella endolysins et utilisations correspondantes - Google Patents

Nouveau gardnerella endolysins et utilisations correspondantes

Info

Publication number
MA55951A
MA55951A MA055951A MA55951A MA55951A MA 55951 A MA55951 A MA 55951A MA 055951 A MA055951 A MA 055951A MA 55951 A MA55951 A MA 55951A MA 55951 A MA55951 A MA 55951A
Authority
MA
Morocco
Prior art keywords
endolysins
gardnerella
new
related uses
new gardnerella
Prior art date
Application number
MA055951A
Other languages
English (en)
Inventor
Lorenzo Corsini
Original Assignee
Biontech R&D Austria Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biontech R&D Austria Gmbh filed Critical Biontech R&D Austria Gmbh
Publication of MA55951A publication Critical patent/MA55951A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462Lysozyme (3.2.1.17)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01017Lysozyme (3.2.1.17)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/00022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
MA055951A 2019-05-08 2020-05-07 Nouveau gardnerella endolysins et utilisations correspondantes MA55951A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19173389 2019-05-08

Publications (1)

Publication Number Publication Date
MA55951A true MA55951A (fr) 2022-03-23

Family

ID=66476422

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055951A MA55951A (fr) 2019-05-08 2020-05-07 Nouveau gardnerella endolysins et utilisations correspondantes

Country Status (14)

Country Link
US (1) US20220315908A1 (fr)
EP (1) EP3969578A1 (fr)
JP (2) JP2022532130A (fr)
KR (1) KR20220007123A (fr)
CN (2) CN120136980A (fr)
AU (2) AU2020268752B2 (fr)
BR (1) BR112021022283A2 (fr)
CA (1) CA3136346A1 (fr)
CL (1) CL2021002901A1 (fr)
IL (1) IL287842A (fr)
MA (1) MA55951A (fr)
MX (1) MX2021013491A (fr)
SG (1) SG11202111067YA (fr)
WO (1) WO2020225335A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4247943A1 (fr) * 2020-11-18 2023-09-27 CC Biotech Ltd. Polypeptides pour le traitement d'infections bactériennes
WO2023083434A1 (fr) * 2021-11-09 2023-05-19 BioNTech SE Arn codant pour la peptidoglycane hydrolase et son utilisation pour le traitement d'une infection bactérienne
CN118804761A (zh) 2022-02-11 2024-10-18 生物技术公司 加德纳菌内溶素的新型治疗用途
DE102022213056A1 (de) 2022-12-05 2024-06-06 Universität Rostock, Körperschaft des öffentlichen Rechts Innovative antimikrobielle Therapie gegen Streptococcus pneumoniae mittels mRNA kodierter Bakteriophagen-Endolysine/Autolysine
CN121079100A (zh) 2023-05-09 2025-12-05 百欧恩泰欧洲股份公司 加德纳菌属内溶素的阴道内制剂
WO2025002339A1 (fr) * 2023-06-30 2025-01-02 上海赛增医疗科技有限公司 Nouvelle lyase modifiée et son utilisation
WO2025024827A1 (fr) * 2023-07-27 2025-01-30 Topaz Biosciences, Inc. Hydrolases de paroi cellulaire ciblant c. acnes
KR20260049580A (ko) 2023-07-27 2026-04-14 토파즈 바이오사이언시스, 인크. 씨. 아크네스를 표적화하는 세포벽 가수분해효소
TW202541833A (zh) 2023-12-12 2025-11-01 德商拜恩技術股份公司 包含內溶素之組合物及其用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0202556D0 (en) * 2002-02-04 2002-03-20 Danisco Novel Protein
DK2037946T3 (en) * 2006-05-05 2015-04-27 Gangagen Inc ANTIMICROBIAL ACTIVITIES DERIVED BY PHAGER
AU2008328584A1 (en) * 2007-11-26 2009-06-04 Plant Bioscience Limited Novel polypeptides having endolysin activity and uses thereof
US20120171188A1 (en) * 2008-08-19 2012-07-05 Hyglos Invest Gmbh Artificial Peptidoglycan Lysing Enzymes and Peptidoglycan Binding Proteins
EP2157100A1 (fr) * 2008-08-19 2010-02-24 Profos AG Enzymes de lyse peptidoglycane artificielles et protéines à liaison de peptidoglycane
GB0815484D0 (en) * 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
SG178440A1 (en) * 2009-08-24 2012-04-27 Univ Leuven Kath New endolysin obpgplys
EP2338916A1 (fr) * 2009-12-23 2011-06-29 Hyglos Invest GmbH Polypeptides chimériques et leur utilisation dans la décolonisation bactérienne
EA037276B1 (ru) * 2010-04-27 2021-03-03 Лисандо Аг Способы устранения или уменьшения бактериальной биопленки
GB201018518D0 (en) * 2010-11-03 2010-12-15 Univ Leuven Kath Novel endolysin
EP2468856A1 (fr) * 2010-12-23 2012-06-27 Lysando Aktiengesellschaft Agents antimicrobiens
US8790639B2 (en) * 2012-03-28 2014-07-29 The United States Of America, As Represented By The Secretary Of Agriculture Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin
SG11201707345VA (en) * 2015-03-12 2017-10-30 Micreos Human Health Bv Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
CN105062992B (zh) * 2015-07-20 2018-05-11 昆明理工大学 一种细胞内溶素和编码此细胞内溶素的多核苷酸
AU2018248060B2 (en) * 2017-04-03 2024-05-23 Sasinapas Co., Ltd. Engineered Gram-negative endolysins
CN111471671B (zh) * 2020-04-16 2022-04-12 中国农业大学 一种具有抑制产气荚膜梭菌活性的蛋白质及其相关生物材料与应用
CN118804761A (zh) * 2022-02-11 2024-10-18 生物技术公司 加德纳菌内溶素的新型治疗用途

Also Published As

Publication number Publication date
CN120136980A (zh) 2025-06-13
SG11202111067YA (en) 2021-11-29
US20220315908A1 (en) 2022-10-06
AU2020268752B2 (en) 2025-12-18
CN113795577A (zh) 2021-12-14
AU2020268752A1 (en) 2021-12-02
EP3969578A1 (fr) 2022-03-23
IL287842A (en) 2022-01-01
JP2022532130A (ja) 2022-07-13
BR112021022283A2 (pt) 2021-12-28
CL2021002901A1 (es) 2022-06-03
WO2020225335A1 (fr) 2020-11-12
CN113795577B (zh) 2025-03-18
MX2021013491A (es) 2022-02-21
KR20220007123A (ko) 2022-01-18
AU2026201469A1 (en) 2026-03-19
CA3136346A1 (fr) 2020-11-12
JP2025026484A (ja) 2025-02-21

Similar Documents

Publication Publication Date Title
MA55951A (fr) Nouveau gardnerella endolysins et utilisations correspondantes
MA50502A (fr) Adénovirus et utilisations associées
EP3762030A4 (fr) Anticorps anti-cd73 et utilisations associées
EP3749312A4 (fr) Lométrexol alpha-polyglutamaté et utilisations associées
EP3807321A4 (fr) Constructions anti-mésothéline et utilisations associées
IL283550A (en) Chemically-modified rnai constructs and uses thereof
EP3790861A4 (fr) Compositions sénolytiques et utilisations associées
EP3749315A4 (fr) Raltitrexed alpha-polyglutamaté et utilisations associées
EP3749318A4 (fr) Raltitrexed gamma-polyglutamaté et utilisations associées
EP3838289A4 (fr) Anticorps anti-tigit et ses utilisations
EP3810182A4 (fr) Néoantigènes et leurs utilisations
EP3752156A4 (fr) Pralatrexate gamma-polyglutamaté et utilisations associées
EP3749316A4 (fr) Pralatrexate alpha-polyglutamaté et utilisations associées
EP3749314A4 (fr) Méthotrexate alpha-polyglutamaté et utilisations associées
EP3735427A4 (fr) Anticorps anti-mct1 et utilisations associées
EP3749320A4 (fr) Aminoptérine alpha-polyglutamatée et utilisations associées
EP3733702A4 (fr) Anticorps anti-lag-3 et utilisations associées
EP3810172A4 (fr) Protéines hétérodimères et utilisations associées
EP3570829A4 (fr) Ligands photoréactifs et utilisations
MA44262A (fr) Bioconjugués et utilisations de ceux-ci
EP3883967A4 (fr) Anticorps anti-cd38 et anti-icam1 et utilisations correspondantes
EP4093768A4 (fr) Constructions cal-t et leurs utilisations
EP3893945A4 (fr) Esters cromoglycique et leurs utilisations
EP3838900A4 (fr) Composés de 3-aryloxy-3-aryl-propylamine et utilisations associées
MA52190A (fr) Anticorps anti-trem-1 et utilisations associées